Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-01-30
2008-09-23
Powers, Fiona T (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S346000, C514S388000, C544S122000, C544S131000, C544S157000, C544S165000, C546S291000, C548S331500
Reexamination Certificate
active
07427618
ABSTRACT:
Novel compounds of the formula (I), in which R1, R2, R3, X and Y have the meaning indicated in Patent claim1,are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.
REFERENCES:
patent: 2003/0026521 (2003-02-01), Amin et al.
patent: 2003/0069250 (2003-04-01), Zhu et al.
patent: 2004/0038858 (2004-02-01), Dorsch et al.
patent: 10102322 (2002-07-01), None
patent: WO 02-48099 (2002-06-01), None
patent: WO 02-079145 (2002-10-01), None
Gould et al., Current Pharmaceutical Design, 9, 2337-2347, 2003.
Kaiser et al., Thrombosis Research, 98, 175-185, 2000.
Morales-Asin, F., Headache, 40, 45-47, 2000.
Wang et al., Stroke, 34, 468-474, 2003.
Cezanne Bertram
Dorsch Dieter
Gleitz Johannes
Mederski Werner
Tsaklakidis Christos
Merck Patent Gesellschaft Mit Beschrankter Haftung
Millen White Zelano & Branigan P.C.
Powers Fiona T
LandOfFree
Ethynyl derivatives as factor Xa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ethynyl derivatives as factor Xa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ethynyl derivatives as factor Xa inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3992028